• Dr Bahl is a highly skilled cancer specialist/ medical oncologist who have obtained his qualifications/ training from top medical institutes in India, including Maulana Azad Medical College and the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi.

• He completed a course on Adverse Drug Reactions, Drug Interactions and Pharmacovigilance at the University of Oxford UK.

•  Dr Bahl holds clinical expertise in Immunotherapy, targeted therapies in combination with chemotherapy, Hormonal therapy, Supportive and Palliative Care. He is reputed for performing the largest single centre number of targeted therapy (cetuximab) in Asia for head and neck cancer treatment.

• As an academic scholar, he has many national & international publications and presentations credited to his name.

• He is also credited to be a part of one of the largest single-centre studies on the outcomes of Acute Myeloid Leukemia in India.

• He is a strong advocate of Precision Cancer Therapy where individual specific treatment plan are tailor made based on the genomic profile of the cancer and further targeting it successfully with various options of immunotherapy /chemotherapy as well as targeted therapies.